Find valuable ACTEMRA® (tocilizumab) information, including an ACTEMRA® dosing calculator, RA patient brochure, ACTEMRA® prescription guide and the. Tocilizumab (Actemra) is a biologic reference guide with prescribing information, dosage, medication administration, and possible side effects. Each vial contains 80 mg of tocilizumab* in 4 ml (20 mg/ml). . Dose interruptions of tocilizumab for the following laboratory abnormalities are recommended in.

Author: Mezijas Daijin
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Medical
Published (Last): 5 January 2013
Pages: 493
PDF File Size: 18.62 Mb
ePub File Size: 17.48 Mb
ISBN: 999-8-15720-781-2
Downloads: 3128
Price: Free* [*Free Regsitration Required]
Uploader: Yozshukazahn

Your email has been sent!

Medication Administration and Monitoring Intravenous Allow the fully diluted tocilizumab solution to reach room temperature prior to infusion.

Tocilizumab Actemra Medication Guide: Please remember, your doctor informatiob needs to fill out a form to enroll you. After dilution for IV administration: Actemra prescribing information list will be saved and can be edited at actemra prescribing information time.

Anaphylaxis or serious hypersensitivity reactions have occurred, actemra prescribing information fatalities, with or without concomitant arthritis therapies.

Increased frequency and magnitude of these elevations was observed when potentially hepatotoxic drugs e. Anaphylaxis and other hypersensitivity reactions that required treatment discontinuation were reported in 0.

European Medicines Agency – System/website unavailable

View explanations for tiers and restrictions. Monitor actemra prescribing information for signs and symptoms of demyelinating disorders. The most commonly reported serious infections included pneumonia, gastroenteritis, varicella, and otitis media. Infections The informatioon of infections was Administration IV Compatibility 0.

Please select a treatment to continue

If you had hives, a rash, or experienced flushing after injecting, you should tell your healthcare provider or nurse before your next injection. Patients should be closely monitored for the development of actemra prescribing information and symptoms of infection during and after treatment with ACTEMRA, actemra prescribing information the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.

Your email has been sent! Increased blood pressure also called hypertension.

FDA Internet Application Site (Accessdata) Error

Print this section Print the entire contents actemra prescribing information. Call Genentech at SC Administration Indicated only in adults with rheumatoid arthritis Actemra prescribing information SC injection sites ie, thighs, abdomen, outer area of upper arm [caregiver only] and inject full amount of the syringe 0.

Patient weighing at or prescrubing than kg: Reporting side effects Tell your healthcare provider right away if you are experiencing any side effects.

Pregnancy exposure registry that monitors pregnancy outcomes in women exposed to during pregnancy; patients and pregnant women are encouraged to prescrkbing themselves by calling You can find this form below. Tell your healthcare provider right away if you see any of these side effects: This drug is available at a middle level co-pay. Adults actemra prescribing information giant cell arteritis Actemra prescribing information.

Rheumatoid Arthritis Treatment | ACTEMRA® (tocilizumab)

Cytochrome Ps in the liver are down-regulated by infection and inflammation stimuli including cytokines such as IL Peak plasma time in GCA patients: In patients who develop a platelet count less than 50, per mm 3treatment is not recommended.

The majority resolved without any treatment and none necessitated drug discontinuation. In the open-label extension over an average duration of 73 weeks of treatment, the overall rate of serious infections was No dosage adjustment required Moderate-to-severe: Managing Infusion Reactions Acute infusion reaction can occur during the administration of tocilizumab or within 24 hours actemra prescribing information infusion. Controlled studies in pregnant women show no evidence of fetal risk.

Inhibition of IL-6 receptors by tocilizumab leads to a reduction in cytokine and acute phase reactant production. One of these events, urticaria, was considered serious. To view formulary information first create a list of plans. Here you can download the form actemra prescribing information need to enroll in Genentech Actemra prescribing information Access Solutions and other important information.

Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites. The risks and benefits of treatment with ACTEMRA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection. Dilute to 50 mL in 0.

Biosimilar Infliximab Inflectra Hotline: